Inspire Medical Systems Stock Alpha and Beta Analysis
| INSP Stock | USD 59.53 0.25 0.42% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Inspire Medical Systems. It also helps investors analyze the systematic and unsystematic risks associated with investing in Inspire Medical over a specified time horizon. Remember, high Inspire Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Inspire Medical's market risk premium analysis include:
Beta 1.61 | Alpha (0.51) | Risk 4.75 | Sharpe Ratio (0.21) | Expected Return (1.01) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Inspire Medical Analysis, Inspire Medical Valuation, Inspire Medical Correlation, Inspire Medical Hype Analysis, Inspire Medical Volatility, Inspire Medical Price History and analyze Inspire Medical Performance. Inspire Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Inspire Medical market risk premium is the additional return an investor will receive from holding Inspire Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Inspire Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Inspire Medical's performance over market.| α | -0.51 | β | 1.61 |
Inspire Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Inspire Medical's Buy-and-hold return. Our buy-and-hold chart shows how Inspire Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Inspire Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Inspire Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inspire Medical shares will generate the highest return on investment. By understating and applying Inspire Medical stock market price indicators, traders can identify Inspire Medical position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Tanh Of Price Series | ||
| Price Floor Movement | ||
| Plus Directional Indicator | ||
| Rate of change | ||
| Simple Moving Average | ||
| Exponential Moving Average | ||
| Tristar Pattern | ||
| Harami Pattern |
Inspire Medical Return and Market Media
The median price of Inspire Medical for the period between Sun, Nov 23, 2025 and Sat, Feb 21, 2026 is 93.67 with a coefficient of variation of 25.34. The daily time series for the period is distributed with a sample standard deviation of 24.15, arithmetic mean of 95.3, and mean deviation of 18.6. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Inspire Medical Systems, Inc. Securities Fraud Class Action Lawsuit Pending Contact Levi Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP | 12/30/2025 |
2 | Bronstein, Gewirtz Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act Class Action Filed Alleging Investor Harm | 01/05/2026 |
3 | Why Inspire Medical Systems Is Down 13.9 percent After CFO Change And Medicare Reimbursement Uncertainty - simplywall.st | 01/23/2026 |
4 | Disposition of 327 shares by Richard Buchholz of Inspire Medical at 66.33 subject to Rule 16b-3 | 02/09/2026 |
5 | Inspire Medical Systems Q4 Earnings What To Expect | 02/10/2026 |
6 | Inspire Medical Systems Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops | 02/11/2026 |
7 | Inspire Medical Systems Price Target Cut to 70.00 by Analysts at Truist Financial | 02/12/2026 |
8 | Disposition of 579 shares by Bryan Phillips of Inspire Medical at 59.76 subject to Rule 16b-3 | 02/13/2026 |
About Inspire Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Inspire or other stocks. Alpha measures the amount that position in Inspire Medical Systems has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.49 | 3.18 | 3.64 | 2.27 | Days Of Inventory On Hand | 128.07 | 237.78 | 398.06 | 417.97 |
Inspire Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Inspire Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inspire Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Inspire Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Inspire Medical. Please utilize our Beneish M Score to check the likelihood of Inspire Medical's management manipulating its earnings.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Inspire Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.